Last $2.22 USD
Change Today +0.02 / 0.91%
Volume 378.2K
RIGL On Other Exchanges
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Raul R. Rodriguez

Chief Executive Officer, President and Director, Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Raul R. Rodriguez has been the Chief Executive Officer of Rigel Pharmaceuticals, Inc., since November 2014 and serves as its President. Mr. Rodriguez served as President and Chief Operating Officer at Rigel Pharmaceuticals, Inc., from March 2010 and June 2004 respectively to November 2014. Mr. Rodriguez served as an Executive Vice President of Rigel Pharmaceuticals Inc., since June 2004. Mr. Rodriguez served as a Senior Vice President of Business Development and ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

Chief Executive Officer, President and Director


Harvard University
Master's Degree
University of Illinois-Urbana-Champaign
The Leland Stanford Junior University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$551,720

Stock Options*

All Other Compensation$1,794
Exercisable Options1,155,139
Unexercisable Options81,250
Total Number of Options1,236,389

Total Compensation*

Total Annual Cash Compensation$553,514
Total Short Term Compensation$551,720
Other Long Term Compensation$1,794
Total Calculated Compensation$1,223,414
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $2.22 USD +0.02


Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at